| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.665 | 0.011 | 0.665 | Toll-Like receptor 7 agonist | 0.23 0.168 CID_53481014 | ||
| 0.664 | 0.011 | 0.664 | Toll-Like receptor agonist | 0.248 0.15 CID_53481014 | ||
| 0.621 | 0.003 | 0.621 | Alcohol oxidase inhibitor | 0.169 0.008 CID_53481014 | ||
| 0.619 | 0.004 | 0.619 | Peroxidase inhibitor | |||
| 0.62 | 0.005 | 0.62 | GABA C receptor rho-3 antagonist | |||
| 0.576 | 0.018 | 0.576 | Vasodilator, peripheral | 0.312 0.091 CID_53481014 | ||
| 0.521 | 0.003 | 0.521 | Porphobilinogen synthase inhibitor | 0.114 0.03 CID_53481014 | ||
| 0.535 | 0.028 | 0.535 | Aldehyde oxidase inhibitor | |||
| 0.503 | 0.031 | 0.503 | 5 Hydroxytryptamine release inhibitor | 0.486 0.037 CID_53481014 | ||
| 0.485 | 0.034 | 0.485 | Calcium channel L-type activator | |||
| 0.451 | 0.01 | 0.451 | Cyclic AMP phosphodiesterase inhibitor | 0.42 0.014 CID_53481014 | ||
| 0.466 | 0.025 | 0.466 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.458 | 0.056 | 0.458 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.424 | 0.063 | 0.524 | Histamine release inhibitor | 0.524 0.022 CID_53481014 | CID_53481014 | |
| 0.444 | 0.086 | 0.596 | Caspase 9 stimulant | 0.596 0.037 CID_53481014 | CID_53481014 | |
| 0.37 | 0.012 | 0.37 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.351 | 0.008 | 0.432 | UDP-glucose 4-epimerase inhibitor | 0.432 0.004 CID_53481014 | CID_53481014 | |
| 0.344 | 0.007 | 0.344 | Cystathionine beta-synthase inhibitor | 0.259 0.014 CID_53481014 | ||
| 0.338 | 0.007 | 0.338 | Bronchodilator | |||
| 0.321 | 0.006 | 0.321 | Ferrochelatase inhibitor | |||
| 0.32 | 0.008 | 0.32 | Nitric-oxide synthase stimulant | 0.235 0.044 CID_53481014 | ||
| 0.347 | 0.035 | 0.347 | Insulysin inhibitor | |||
| 0.332 | 0.031 | 0.332 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.295 | 0.004 | 0.295 | Creatine kinase inhibitor | 0.108 0.051 CID_53481014 | ||
| 0.374 | 0.089 | 0.664 | Antibacterial | 0.664 0.012 CID_53481014 | CID_53481014 | |
| 0.327 | 0.047 | 0.327 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.335 | 0.061 | 0.335 | Calcium channel activator | |||
| 0.304 | 0.031 | 0.304 | RNA-directed DNA polymerase inhibitor | 0.205 0.092 CID_53481014 | ||
| 0.315 | 0.045 | 0.315 | Superoxide dismutase inhibitor | |||
| 0.274 | 0.004 | 0.274 | Phenylalanine 4-hydroxylase inhibitor | 0.08 0.037 CID_53481014 | ||
| 0.267 | 0.003 | 0.267 | Nicotinic acid receptor 1 agonist | |||
| 0.272 | 0.008 | 0.272 | GABA C receptor rho-2 antagonist | |||
| 0.273 | 0.009 | 0.368 | ATPase inhibitor | 0.368 0.004 CID_53481014 | CID_53481014 | |
| 0.297 | 0.035 | 0.297 | Gastrin inhibitor | 0.189 0.165 CID_53481014 | ||
| 0.312 | 0.053 | 0.312 | DNA damaging | 0.244 0.084 CID_53481014 | ||
| 0.265 | 0.008 | 0.265 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.221 0.013 CID_53481014 | ||
| 0.275 | 0.019 | 0.275 | Heat shock protein 90 alpha antagonist | |||
| 0.304 | 0.049 | 0.304 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.258 | 0.004 | 0.258 | Adrenaline agonist | |||
| 0.316 | 0.065 | 0.316 | 5 Hydroxytryptamine release stimulant | 0.221 0.106 CID_53481014 | ||
| 0.263 | 0.012 | 0.263 | GABA C receptor agonist | |||
| 0.267 | 0.017 | 0.267 | Succinate dehydrogenase inhibitor | 0.142 0.129 CID_53481014 | ||
| 0.268 | 0.021 | 0.268 | Acetylcholine M1 receptor antagonist | |||
| 0.264 | 0.017 | 0.264 | Heat shock protein 90 antagonist | |||
| 0.26 | 0.016 | 0.26 | Aldehyde dehydrogenase inhibitor | 0.151 0.047 CID_53481014 | ||
| 0.29 | 0.047 | 0.36 | DNA synthesis inhibitor | 0.36 0.028 CID_53481014 | CID_53481014 | |
| 0.272 | 0.033 | 0.272 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.27 0.034 CID_53481014 | ||
| 0.257 | 0.019 | 0.257 | NADPH oxidase inhibitor | |||
| 0.288 | 0.056 | 0.288 | Dyrk kinase inhibitor | |||
| 0.338 | 0.106 | 0.338 | 15-Lipoxygenase inhibitor | |||
| 0.25 | 0.023 | 0.406 | Alpha-N-acetylglucosaminidase inhibitor | 0.406 0.009 CID_53481014 | CID_53481014 | |
| 0.231 | 0.007 | 0.231 | NMDA 2 receptor antagonist | |||
| 0.299 | 0.079 | 0.299 | Streptokinase A inhibitor | |||
| 0.274 | 0.055 | 0.274 | Pyruvate kinase inhibitor | |||
| 0.266 | 0.047 | 0.266 | MAP kinase kinase 2 inhibitor | |||
| 0.229 | 0.012 | 0.229 | Carbonic anhydrase III inhibitor | 0.119 0.045 CID_53481014 | ||
| 0.288 | 0.072 | 0.358 | Hypoxia-inducible factor 1 alpha inhibitor | 0.358 0.042 CID_53481014 | CID_53481014 | |
| 0.225 | 0.011 | 0.225 | Androgen antagonist | |||
| 0.29 | 0.076 | 0.29 | Lipoxygenase inhibitor | |||
| 0.233 | 0.025 | 0.233 | Glycogen synthase kinase-3 inhibitor | |||
| 0.227 | 0.02 | 0.227 | Death-associated protein kinase 2 inhibitor | |||
| 0.218 | 0.011 | 0.218 | Histidine decarboxylase inhibitor | |||
| 0.245 | 0.042 | 0.245 | Neurotrophic factor enhancer | 0.235 0.047 CID_53481014 | ||
| 0.258 | 0.055 | 0.319 | Amyloid beta aggregation inhibitor | 0.319 0.041 CID_53481014 | CID_53481014 | |
| 0.265 | 0.063 | 0.55 | Free radical scavenger | 0.55 0.012 CID_53481014 | CID_53481014 | |
| 0.22 | 0.021 | 0.35 | Mannose-6-phosphate isomerase inhibitor | 0.35 0.004 CID_53481014 | CID_53481014 | |
| 0.21 | 0.011 | 0.21 | Antineoplastic alkaloid | |||
| 0.209 | 0.011 | 0.209 | GABA C receptor antagonist | |||
| 0.245 | 0.048 | 0.245 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.208 | 0.013 | 0.208 | NMDA receptor antagonist | |||
| 0.213 | 0.023 | 0.304 | Topoisomerase I inhibitor | 0.304 0.01 CID_53481014 | CID_53481014 | |
| 0.263 | 0.073 | 0.263 | Aryl hydrocarbon receptor agonist | |||
| 0.198 | 0.015 | 0.198 | Mediator release inhibitor | 0.196 0.015 CID_53481014 | ||
| 0.189 | 0.007 | 0.189 | Phosphodiesterase III inhibitor | |||
| 0.275 | 0.095 | 0.275 | 12-Lipoxygenase inhibitor | |||
| 0.208 | 0.027 | 0.208 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.251 | 0.078 | 0.348 | Interleukin agonist | 0.348 0.029 CID_53481014 | CID_53481014 | |
| 0.182 | 0.011 | 0.182 | Heat shock protein 70 antagonist | 0.16 0.028 CID_53481014 | ||
| 0.21 | 0.041 | 0.415 | Amylase inhibitor | 0.415 0.009 CID_53481014 | CID_53481014 | |
| 0.185 | 0.016 | 0.219 | Photosensitizer | 0.219 0.009 CID_53481014 | CID_53481014 | |
| 0.193 | 0.026 | 0.193 | Acetylcholine muscarinic antagonist | |||
| 0.178 | 0.012 | 0.178 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.178 | 0.014 | 0.233 | DNA repair enzyme inhibitor | 0.233 0.006 CID_53481014 | CID_53481014 | |
| 0.212 | 0.049 | 0.212 | Dual specificity phosphatase inhibitor | |||
| 0.176 | 0.013 | 0.375 | NADH dehydrogenase inhibitor | 0.375 0.005 CID_53481014 | CID_53481014 | |
| 0.168 | 0.005 | 0.168 | Dopamine D2 agonist | |||
| 0.172 | 0.01 | 0.172 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.079 0.066 CID_53481014 | ||
| 0.174 | 0.013 | 0.174 | GABA C receptor rho-1 antagonist | |||
| 0.232 | 0.072 | 0.232 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.245 | 0.086 | 0.596 | Antioxidant | 0.596 0.012 CID_53481014 | CID_53481014 | |
| 0.192 | 0.04 | 0.381 | Hexokinase inhibitor | 0.381 0.005 CID_53481014 | CID_53481014 | |
| 0.166 | 0.016 | 0.32 | Triose-phosphate isomerase inhibitor | 0.32 0.004 CID_53481014 | CID_53481014 | |
| 0.263 | 0.116 | 0.591 | Cholesterol antagonist | 0.591 0.02 CID_53481014 | CID_53481014 | |
| 0.159 | 0.012 | 0.159 | Nav1.8 sodium channel blocker | |||
| 0.183 | 0.037 | 0.183 | Cholinergic antagonist | |||
| 0.167 | 0.023 | 0.167 | Potassium channel (Ca-activated) activator | |||
| 0.151 | 0.007 | 0.151 | NMDA 2C receptor antagonist | |||
| 0.178 | 0.034 | 0.178 | Glutamate receptor antagonist | |||
| 0.18 | 0.037 | 0.18 | Acetylcholine antagonist | |||
| 0.15 | 0.008 | 0.15 | Acetylcholine M5 receptor antagonist | |||
| 0.182 | 0.041 | 0.182 | Alkaline phosphatase inhibitor | 0.18 0.042 CID_53481014 | ||
| 0.206 | 0.066 | 0.332 | DNA methyltransferase I inhibitor | 0.332 0.017 CID_53481014 | CID_53481014 | |
| 0.151 | 0.011 | 0.151 | Acetylcholine M3 receptor antagonist | |||
| 0.183 | 0.046 | 0.183 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.16 | 0.023 | 0.16 | Adenylate kinase inhibitor | 0.125 0.04 CID_53481014 | ||
| 0.231 | 0.094 | 0.231 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.193 | 0.057 | 0.193 | Tumour necrosis factor antagonist | |||
| 0.141 | 0.007 | 0.141 | Beta 3 adrenoreceptor antagonist | |||
| 0.169 | 0.036 | 0.169 | Adenylate cyclase stimulant | |||
| 0.164 | 0.032 | 0.164 | Aminopeptidase B inhibitor | |||
| 0.152 | 0.02 | 0.152 | Carbonic anhydrase VI inhibitor | |||
| 0.173 | 0.043 | 0.173 | CF transmembrane conductance regulator agonist | 0.135 0.106 CID_53481014 | ||
| 0.136 | 0.007 | 0.136 | NMDA receptor subunit 3B antagonist | |||
| 0.248 | 0.12 | 0.426 | Interleukin 2 agonist | 0.426 0.021 CID_53481014 | CID_53481014 | |
| 0.156 | 0.028 | 0.156 | Protein kinase C gamma inhibitor | |||
| 0.149 | 0.022 | 0.149 | DOPA decarboxylase inhibitor | |||
| 0.135 | 0.008 | 0.135 | Beta adrenoreceptor antagonist | |||
| 0.141 | 0.015 | 0.141 | Cyclin B3 inhibitor | |||
| 0.134 | 0.009 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.155 | 0.032 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 CID_53481014 | CID_53481014 | |
| 0.178 | 0.056 | 0.178 | Arachidonic acid antagonist | |||
| 0.144 | 0.022 | 0.144 | Alcohol dehydrogenase inhibitor | 0.13 0.028 CID_53481014 | ||
| 0.194 | 0.073 | 0.194 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.15 | 0.029 | 0.414 | AMP-activated protein kinase stimulant | 0.414 0.004 CID_53481014 | CID_53481014 | |
| 0.137 | 0.017 | 0.137 | Dopamine agonist | |||
| 0.214 | 0.094 | 0.314 | Vasodilator | 0.314 0.043 CID_53481014 | CID_53481014 | |
| 0.146 | 0.027 | 0.333 | Beta glucuronidase inhibitor | 0.333 0.005 CID_53481014 | CID_53481014 | |
| 0.121 | 0.004 | 0.121 | Beta 2 adrenoreceptor agonist | |||
| 0.123 | 0.006 | 0.123 | Beta 2 adrenoreceptor antagonist | |||
| 0.169 | 0.053 | 0.169 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.135 | 0.02 | 0.135 | Macrophage migration inhibitory factor inhibitor | |||
| 0.172 | 0.059 | 0.172 | Neurotensin receptor agonist | |||
| 0.149 | 0.036 | 0.149 | 5 Hydroxytryptamine 3A agonist | |||
| 0.195 | 0.082 | 0.345 | DNA methylase inhibitor | 0.345 0.018 CID_53481014 | CID_53481014 | |
| 0.125 | 0.015 | 0.135 | Glycine receptor antagonist | 0.135 0.012 CID_53481014 | CID_53481014 | |
| 0.121 | 0.012 | 0.121 | NMDA 2B receptor antagonist | |||
| 0.189 | 0.08 | 0.189 | I kappa B kinase epsilon inhibitor | |||
| 0.122 | 0.013 | 0.122 | Biliverdin reductase inhibitor | 0.062 0.038 CID_53481014 | ||
| 0.192 | 0.084 | 0.192 | Psychostimulant | |||
| 0.135 | 0.029 | 0.135 | Prolactin inhibitor | |||
| 0.147 | 0.042 | 0.147 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.124 | 0.019 | 0.124 | Glutamate decarboxylase inhibitor | |||
| 0.125 | 0.021 | 0.125 | Phosphodiesterase 3A inhibitor | |||
| 0.155 | 0.053 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.157 | 0.055 | 0.157 | Tubulin antagonist | |||
| 0.117 | 0.015 | 0.117 | D-Ala-D-Ala ligase inhibitor | |||
| 0.161 | 0.061 | 0.271 | Lipid peroxidase inhibitor | 0.271 0.023 CID_53481014 | CID_53481014 | |
| 0.117 | 0.018 | 0.117 | Potassium channel large-conductance Ca-activated activator | |||
| 0.129 | 0.03 | 0.129 | Electrolyte absorption antagonist | |||
| 0.147 | 0.048 | 0.216 | Alkylator | 0.216 0.022 CID_53481014 | CID_53481014 | |
| 0.138 | 0.04 | 0.138 | Chelator | 0.122 0.051 CID_53481014 | ||
| 0.182 | 0.085 | 0.182 | Anesthetic general | 0.179 0.088 CID_53481014 | ||
| 0.106 | 0.009 | 0.106 | Heat shock protein 90 beta antagonist | |||
| 0.108 | 0.013 | 0.108 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.105 0.013 CID_53481014 | ||
| 0.186 | 0.091 | 0.186 | Histone acetyltransferase inhibitor | |||
| 0.116 | 0.022 | 0.116 | Myeloperoxidase inhibitor | |||
| 0.146 | 0.052 | 0.325 | Topoisomerase II inhibitor | 0.325 0.015 CID_53481014 | CID_53481014 | |
| 0.133 | 0.041 | 0.133 | Antiadrenergic | |||
| 0.105 | 0.013 | 0.105 | Androgen agonist | |||
| 0.168 | 0.076 | 0.168 | Phospholipase C inhibitor | 0.151 0.105 CID_53481014 | ||
| 0.102 | 0.01 | 0.102 | Glutamate (mGluR7) antagonist | |||
| 0.279 | 0.188 | 0.535 | Apoptosis agonist | 0.535 0.064 CID_53481014 | CID_53481014 | |
| 0.16 | 0.069 | 0.277 | Melanin inhibitor | 0.277 0.025 CID_53481014 | CID_53481014 | |
| 0.127 | 0.036 | 0.127 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.13 | 0.04 | 0.13 | Adrenaline antagonist | |||
| 0.21 | 0.121 | 0.21 | Transcription factor STAT3 inhibitor | |||
| 0.095 | 0.005 | 0.095 | Dihydroorotate oxidase inhibitor | |||
| 0.104 | 0.015 | 0.104 | Purinergic P2X1 antagonist | 0.079 0.026 CID_53481014 | ||
| 0.099 | 0.01 | 0.099 | Beta 1 adrenoreceptor antagonist | |||
| 0.1 | 0.011 | 0.1 | Phosphodiesterase 3B inhibitor | |||
| 0.107 | 0.018 | 0.107 | Estrogen-related receptor beta agonist | |||
| 0.133 | 0.045 | 0.133 | 5-Lipoxygenase inhibitor | |||
| 0.111 | 0.023 | 0.111 | mTOR complex 2 inhibitor | |||
| 0.102 | 0.015 | 0.102 | GABA B receptor agonist | |||
| 0.135 | 0.049 | 0.178 | DNA intercalator | 0.178 0.033 CID_53481014 | CID_53481014 | |
| 0.113 | 0.027 | 0.123 | Glutamate release inhibitor | 0.123 0.02 CID_53481014 | CID_53481014 | |
| 0.099 | 0.015 | 0.099 | 5 Hydroxytryptamine 2A agonist | |||
| 0.098 | 0.014 | 0.098 | MAP kinase kinase 7 inhibitor | |||
| 0.138 | 0.054 | 0.138 | Proteasome inhibitor | |||
| 0.154 | 0.07 | 0.154 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.123 | 0.039 | 0.123 | CDC-like kinase 3 inhibitor | |||
| 0.088 | 0.004 | 0.088 | Beta adrenoreceptor agonist | |||
| 0.117 | 0.035 | 0.117 | Estrogen receptor beta antagonist | |||
| 0.129 | 0.048 | 0.129 | Caspase 3 inhibitor | |||
| 0.091 | 0.011 | 0.091 | Cyclin D1 inhibitor | |||
| 0.098 | 0.018 | 0.098 | NMDA receptor glycine site agonist | |||
| 0.097 | 0.017 | 0.097 | Phospholipase D inhibitor | |||
| 0.112 | 0.033 | 0.112 | Carbonic anhydrase XIII inhibitor | 0.081 0.049 CID_53481014 | ||
| 0.098 | 0.019 | 0.098 | Argininosuccinate synthase inhibitor | |||
| 0.106 | 0.028 | 0.106 | Glutamate dehydrogenase inhibitor | 0.075 0.05 CID_53481014 | ||
| 0.132 | 0.054 | 0.132 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.199 | 0.121 | 0.202 | Spasmolytic | 0.202 0.118 CID_53481014 | CID_53481014 | |
| 0.136 | 0.058 | 0.136 | Cathepsin H inhibitor | |||
| 0.164 | 0.087 | 0.164 | Amyloid beta precursor protein antagonist | |||
| 0.259 | 0.182 | 0.517 | Alpha-glucosidase inhibitor | 0.517 0.076 CID_53481014 | CID_53481014 | |
| 0.106 | 0.029 | 0.202 | Phosphofructokinase-1 inhibitor | 0.202 0.011 CID_53481014 | CID_53481014 | |
| 0.185 | 0.108 | 0.185 | ErbB-1 antagonist | |||
| 0.097 | 0.021 | 0.097 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.223 | 0.148 | 0.572 | Transcription factor NF kappa B inhibitor | 0.572 0.035 CID_53481014 | CID_53481014 | |
| 0.081 | 0.006 | 0.081 | Dopamine D5 agonist | |||
| 0.147 | 0.073 | 0.147 | CDC-like kinase 1 inhibitor | |||
| 0.129 | 0.056 | 0.324 | Monophenol monooxygenase inhibitor | 0.324 0.015 CID_53481014 | CID_53481014 | |
| 0.103 | 0.029 | 0.103 | Keratolytic | |||
| 0.088 | 0.015 | 0.088 | AMPA receptor antagonist | |||
| 0.084 | 0.011 | 0.084 | NMDA receptor subunit 3A antagonist | |||
| 0.123 | 0.05 | 0.123 | Estrogen antagonist | |||
| 0.091 | 0.019 | 0.091 | Protein kinase C beta inhibitor | |||
| 0.124 | 0.054 | 0.124 | TRPA1 agonist | |||
| 0.131 | 0.061 | 0.156 | DNA polymerase I inhibitor | 0.156 0.046 CID_53481014 | CID_53481014 | |
| 0.134 | 0.064 | 0.134 | Toll-Like receptor 2 antagonist | |||
| 0.076 | 0.007 | 0.076 | Nicotinic acid receptor agonist | |||
| 0.089 | 0.02 | 0.089 | Xanthine dehydrogenase inhibitor | |||
| 0.125 | 0.056 | 0.143 | Microtubule formation inhibitor | 0.143 0.041 CID_53481014 | CID_53481014 | |
| 0.116 | 0.049 | 0.116 | Urease inhibitor | |||
| 0.225 | 0.158 | 0.388 | Vasodilator, coronary | 0.388 0.039 CID_53481014 | CID_53481014 | |
| 0.113 | 0.046 | 0.113 | Anabolic | |||
| 0.135 | 0.069 | 0.135 | Death-associated protein kinase 1 inhibitor | |||
| 0.083 | 0.017 | 0.083 | MDM2 inhibitor | |||
| 0.096 | 0.03 | 0.096 | GABA aminotransferase inhibitor | 0.094 0.032 CID_53481014 | ||
| 0.156 | 0.091 | 0.156 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.118 | 0.053 | 0.118 | MAO A inhibitor | |||
| 0.143 | 0.079 | 0.143 | MAP kinase 3 inhibitor | |||
| 0.089 | 0.025 | 0.089 | Acetylcholine M2 receptor antagonist | |||
| 0.072 | 0.011 | 0.072 | CDK5/p25 inhibitor | |||
| 0.069 | 0.01 | 0.069 | Purinergic P2X4 antagonist | |||
| 0.08 | 0.022 | 0.08 | Carbonic anhydrase VB inhibitor | |||
| 0.084 | 0.027 | 0.084 | NMDA receptor agonist | |||
| 0.141 | 0.084 | 0.141 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.219 | 0.163 | 0.219 | Sodium/bile acid cotransporter inhibitor | |||
| 0.109 | 0.053 | 0.196 | Xanthine oxidase inhibitor | 0.196 0.02 CID_53481014 | CID_53481014 | |
| 0.197 | 0.142 | 0.197 | Transcription factor STAT inhibitor | |||
| 0.139 | 0.084 | 0.342 | NOS3 expression enhancer | 0.342 0.012 CID_53481014 | CID_53481014 | |
| 0.099 | 0.046 | 0.099 | Phosphodiesterase IV inhibitor | |||
| 0.088 | 0.035 | 0.088 | CDC25A inhibitor | |||
| 0.183 | 0.131 | 0.431 | Immunostimulant | 0.431 0.041 CID_53481014 | CID_53481014 | |
| 0.083 | 0.032 | 0.083 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.141 | 0.09 | 0.141 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.059 | 0.008 | 0.059 | Kainate receptor agonist | |||
| 0.057 | 0.006 | 0.057 | Uridine phosphorylase inhibitor | 0.029 0.019 CID_53481014 | ||
| 0.092 | 0.042 | 0.092 | Catalase inhibitor | |||
| 0.098 | 0.048 | 0.098 | Histamine N-methyltransferase inhibitor | |||
| 0.1 | 0.051 | 0.1 | Protein kinase C zeta inhibitor | |||
| 0.107 | 0.059 | 0.107 | Carbonic anhydrase XV inhibitor | |||
| 0.111 | 0.064 | 0.118 | Mucolytic | 0.118 0.056 CID_53481014 | CID_53481014 | |
| 0.147 | 0.101 | 0.147 | LIM domain kinase 1 inhibitor | |||
| 0.067 | 0.02 | 0.067 | Aconitate hydratase inhibitor | |||
| 0.124 | 0.078 | 0.124 | Vanilloid 1 agonist | |||
| 0.123 | 0.077 | 0.123 | Antibacterial (Helicobacter pylori) | |||
| 0.074 | 0.028 | 0.074 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.088 | 0.042 | 0.088 | CC chemokine 5 receptor agonist | |||
| 0.209 | 0.164 | 0.209 | Thioredoxin glutathione reductase inhibitor | |||
| 0.059 | 0.014 | 0.059 | Glutamate (mGluR group III) antagonist | |||
| 0.07 | 0.025 | 0.07 | Botulinum neurotoxin type A inhibitor | |||
| 0.188 | 0.145 | 0.188 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.126 | 0.083 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.062 | 0.019 | 0.062 | Phosphodiesterase 7A inhibitor | |||
| 0.08 | 0.038 | 0.08 | Glycine receptor agonist | 0.077 0.043 CID_53481014 | ||
| 0.066 | 0.025 | 0.066 | Cyclin B2 inhibitor | |||
| 0.167 | 0.126 | 0.397 | Antiamyloidogenic | 0.397 0.029 CID_53481014 | CID_53481014 | |
| 0.068 | 0.028 | 0.068 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.156 | 0.116 | 0.156 | Antimitotic | |||
| 0.064 | 0.026 | 0.064 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.094 | 0.055 | 0.094 | Potassium channel activator | |||
| 0.057 | 0.019 | 0.057 | Dihydroorotase inhibitor | |||
| 0.079 | 0.043 | 0.079 | HIV-1 reverse transcriptase inhibitor | |||
| 0.1 | 0.064 | 0.1 | Protein kinase (CK2) inhibitor | |||
| 0.185 | 0.15 | 0.185 | Neuropeptide Y2 antagonist | |||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR4) antagonist | |||
| 0.078 | 0.044 | 0.078 | Aminopeptidase I inhibitor | |||
| 0.157 | 0.123 | 0.181 | Insulin sensitizer | 0.181 0.094 CID_53481014 | CID_53481014 | |
| 0.075 | 0.041 | 0.075 | Carbonic anhydrase VA inhibitor | |||
| 0.049 | 0.015 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.039 | 0.005 | 0.039 | Beta 1 adrenoreceptor agonist | |||
| 0.091 | 0.057 | 0.091 | Phosphodiesterase I inhibitor | |||
| 0.048 | 0.014 | 0.048 | Fumarate hydratase inhibitor | |||
| 0.064 | 0.031 | 0.064 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.06 | 0.028 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.013 CID_53481014 | CID_53481014 | |
| 0.064 | 0.031 | 0.064 | Fatty acid synthase inhibitor | |||
| 0.046 | 0.013 | 0.046 | CF transmembrane conductance regulator antagonist | |||
| 0.043 | 0.012 | 0.043 | Catechol O-methyltransferase inhibitor | |||
| 0.054 | 0.023 | 0.054 | Thymidylate synthase inhibitor | |||
| 0.038 | 0.009 | 0.038 | CXC chemokine 2 receptor antagonist | |||
| 0.066 | 0.037 | 0.066 | Transcription factor RelA inhibitor | |||
| 0.154 | 0.125 | 0.154 | Focal adhesion kinase 2 inhibitor | |||
| 0.047 | 0.018 | 0.047 | AMPA 4 receptor antagonist | |||
| 0.047 | 0.018 | 0.047 | Histone deacetylase 9 inhibitor | |||
| 0.064 | 0.035 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.056 | 0.027 | 0.056 | CXC chemokine 1 receptor antagonist | |||
| 0.202 | 0.174 | 0.503 | Antithrombotic | 0.503 0.029 CID_53481014 | CID_53481014 | |
| 0.068 | 0.04 | 0.068 | CDC25B inhibitor | |||
| 0.117 | 0.09 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.047 | 0.02 | 0.047 | 5-Alpha-reductase inhibitor | |||
| 0.078 | 0.051 | 0.078 | Estrogen receptor alpha antagonist | |||
| 0.088 | 0.061 | 0.116 | ATPase (Vacuolar H+) inhibitor | 0.116 0.022 CID_53481014 | CID_53481014 | |
| 0.031 | 0.005 | 0.031 | Progesterone receptor B antagonist | |||
| 0.065 | 0.038 | 0.065 | Cyclin B1 inhibitor | |||
| 0.035 | 0.009 | 0.035 | Thyroid hormone agonist | |||
| 0.132 | 0.106 | 0.132 | MAP kinase kinase 4 inhibitor | |||
| 0.069 | 0.044 | 0.069 | Carbonic anhydrase V inhibitor | |||
| 0.151 | 0.127 | 0.151 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.058 | 0.034 | 0.058 | Cyclin B inhibitor | |||
| 0.107 | 0.083 | 0.107 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.092 | 0.068 | 0.092 | MAP kinase kinase 1 inhibitor | |||
| 0.128 | 0.104 | 0.128 | Pregnane X receptor agonist | |||
| 0.06 | 0.037 | 0.06 | Ryanodine receptor antagonist | |||
| 0.034 | 0.011 | 0.034 | Dopamine autoreceptor agonist | |||
| 0.045 | 0.023 | 0.045 | Thymidine kinase inhibitor | |||
| 0.047 | 0.026 | 0.047 | AICAR transformylase inhibitor | |||
| 0.047 | 0.027 | 0.047 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.13 | 0.11 | 0.24 | Interferon gamma antagonist | 0.24 0.03 CID_53481014 | CID_53481014 | |
| 0.024 | 0.005 | 0.024 | Egl nine homolog 1 inhibitor | |||
| 0.144 | 0.124 | 0.426 | Non-steroidal antiinflammatory agent | 0.426 0.011 CID_53481014 | CID_53481014 | |
| 0.066 | 0.047 | 0.066 | Leukotriene synthesis inhibitor | |||
| 0.032 | 0.013 | 0.032 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.049 | 0.031 | 0.081 | Glucose-6-phosphate isomerase inhibitor | 0.081 0.008 CID_53481014 | CID_53481014 | |
| 0.053 | 0.035 | 0.053 | NMDA 2A receptor antagonist | |||
| 0.054 | 0.036 | 0.065 | Aldose reductase inhibitor | 0.065 0.03 CID_53481014 | CID_53481014 | |
| 0.066 | 0.049 | 0.066 | Glutamate (mGluR6) antagonist | |||
| 0.04 | 0.022 | 0.04 | Kainate receptor 2 antagonist | |||
| 0.043 | 0.026 | 0.043 | Kainate receptor antagonist | |||
| 0.093 | 0.076 | 0.093 | Glutamate (mGluR7) agonist | |||
| 0.084 | 0.067 | 0.084 | Bromodomain-containing protein 2 inhibitor | |||
| 0.05 | 0.034 | 0.05 | Sodium/calcium exchanger inhibitor | |||
| 0.029 | 0.013 | 0.029 | Thymidine phosphorylase inhibitor | |||
| 0.104 | 0.088 | 0.104 | Interleukin 8 antagonist | |||
| 0.058 | 0.042 | 0.077 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.077 0.026 CID_53481014 | CID_53481014 | |
| 0.037 | 0.021 | 0.037 | RNA-directed RNA polymerase inhibitor | |||
| 0.061 | 0.046 | 0.061 | Phosphodiesterase VII inhibitor | |||
| 0.038 | 0.023 | 0.038 | Glutamate (mGluR3) antagonist | |||
| 0.055 | 0.04 | 0.055 | Immunoglobulin Fc receptor antagonist | |||
| 0.032 | 0.018 | 0.032 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.034 | 0.02 | 0.034 | Protein kinase (CK2) beta inhibitor | |||
| 0.028 | 0.014 | 0.028 | NMDA receptor glycine site antagonist | |||
| 0.067 | 0.053 | 0.067 | Prostaglandin-E synthase inhibitor | |||
| 0.056 | 0.042 | 0.056 | Pregnane X receptor antagonist | |||
| 0.099 | 0.085 | 0.099 | Adenylate cyclase inhibitor | |||
| 0.183 | 0.169 | 0.183 | Prostaglandin dehydrogenase inhibitor | |||
| 0.075 | 0.061 | 0.191 | Antineoplastic antibiotic | 0.191 0.023 CID_53481014 | CID_53481014 | |
| 0.102 | 0.089 | 0.102 | MAO inhibitor | |||
| 0.126 | 0.113 | 0.126 | CDC-like kinase 2 inhibitor | |||
| 0.017 | 0.005 | 0.017 | Egl nine homolog 3 inhibitor | |||
| 0.061 | 0.049 | 0.061 | Dopamine D1 antagonist | |||
| 0.032 | 0.02 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.054 | 0.042 | 0.054 | 5 Hydroxytryptamine 7 agonist | |||
| 0.089 | 0.078 | 0.105 | Phosphodiesterase 6D inhibitor | 0.105 0.044 CID_53481014 | CID_53481014 | |
| 0.089 | 0.077 | 0.089 | Bile acid receptor antagonist | |||
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.039 | 0.028 | 0.039 | Dihydropteroate synthase inhibitor | |||
| 0.048 | 0.037 | 0.059 | Topoisomerase II beta inhibitor | 0.059 0.023 CID_53481014 | CID_53481014 | |
| 0.038 | 0.027 | 0.038 | Glutamate (mGluR8) agonist | |||
| 0.059 | 0.049 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.128 | 0.118 | 0.128 | Dual specificity phosphatase 3 inhibitor | |||
| 0.046 | 0.037 | 0.046 | Plasminogen activator inhibitor antagonist | |||
| 0.041 | 0.032 | 0.041 | GABA B receptor antagonist | |||
| 0.027 | 0.018 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.023 | 0.015 | 0.026 | Dopamine D1 agonist | 0.026 0.012 CID_53481014 | CID_53481014 | |
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.044 | 0.035 | 0.044 | Adenylate cyclase 1 inhibitor | |||
| 0.051 | 0.043 | 0.051 | Protein kinase C eta inhibitor | |||
| 0.027 | 0.02 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.037 | 0.029 | 0.037 | Alpha 1d adrenoreceptor agonist | |||
| 0.033 | 0.026 | 0.033 | Progesterone antagonist | |||
| 0.035 | 0.028 | 0.035 | Integrin alpha2 antagonist | |||
| 0.076 | 0.069 | 0.076 | Glutathione S-transferase inhibitor | |||
| 0.028 | 0.021 | 0.028 | Cyclin E2 inhibitor | |||
| 0.077 | 0.07 | 0.077 | Thioredoxin reductase inhibitor | |||
| 0.039 | 0.033 | 0.039 | Oxytocin agonist | |||
| 0.032 | 0.026 | 0.032 | Protein kinase C beta I inhibitor | |||
| 0.01 | 0.004 | 0.01 | DNA topoisomerase III inhibitor | |||
| 0.035 | 0.03 | 0.035 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.026 | 0.02 | 0.026 | Integrin alpha2beta1 antagonist | |||
| 0.028 | 0.022 | 0.028 | AMPA 3 receptor antagonist | |||
| 0.046 | 0.041 | 0.046 | Dopamine beta hydroxylase inhibitor | |||
| 0.046 | 0.042 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.035 | 0.031 | 0.035 | TRPM8 blocker | |||
| 0.046 | 0.041 | 0.046 | Carbonic anhydrase XII inhibitor | |||
| 0.037 | 0.033 | 0.037 | Acid-sensing ion channel blocker | |||
| 0.109 | 0.106 | 0.26 | Protein kinase stimulant | 0.26 0.024 CID_53481014 | CID_53481014 | |
| 0.103 | 0.099 | 0.103 | Transcription factor STAT6 inhibitor | |||
| 0.04 | 0.037 | 0.066 | Phosphorylase inhibitor | 0.066 0.022 CID_53481014 | CID_53481014 | |
| 0.058 | 0.055 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.025 | 0.023 | 0.025 | AMPA 1 receptor antagonist | |||
| 0.054 | 0.053 | 0.054 | CDK1/cyclin B inhibitor | |||
| 0.014 | 0.013 | 0.014 | Purinergic P2Y1 antagonist | |||
| 0.086 | 0.087 | 0.234 | Expectorant | 0.234 0.015 CID_53481014 | CID_53481014 | |
| 0.017 | 0.019 | 0.035 | Antibiotic Anthracycline-like | 0.035 0.003 CID_53481014 | CID_53481014 | |
| 0.046 | 0.048 | 0.051 | Maillard reaction inhibitor | 0.051 0.042 CID_53481014 | CID_53481014 | |
| 0.11 | 0.116 | 0.242 | Cell wall synthesis inhibitor | 0.242 0.018 CID_53481014 | CID_53481014 | |
| 0.046 | 0.054 | 0.072 | Alpha-mannosidase inhibitor | 0.072 0.016 CID_53481014 | CID_53481014 | |
| 0.036 | 0.045 | 0.041 | Adenosine deaminase inhibitor | 0.041 0.039 CID_53481014 | CID_53481014 | |
| 0.096 | 0.109 | 0.238 | Cyclooxygenase 3 inhibitor | 0.238 0.01 CID_53481014 | CID_53481014 | |
| 0.036 | 0.049 | 0.069 | Mannosidase inhibitor | 0.069 0.012 CID_53481014 | CID_53481014 | |
| 0.049 | 0.065 | 0.07 | HIV-1 integrase (3'-Processing) inhibitor | 0.07 0.039 CID_53481014 | CID_53481014 | |
| 0.028 | 0.045 | 0.033 | Tubulin agonist | 0.033 0.027 CID_53481014 | CID_53481014 | |
| 0.037 | 0.055 | 0.088 | Carbonic anhydrase XIV inhibitor | 0.088 0.014 CID_53481014 | CID_53481014 | |
| 0.02 | 0.04 | 0.088 | Sodium/glucose cotransporter inhibitor | 0.088 0.003 CID_53481014 | CID_53481014 | |
| 0.039 | 0.062 | 0.128 | Factor IXa inhibitor | 0.128 0.005 CID_53481014 | CID_53481014 | |
| 0.011 | 0.035 | 0.02 | Telomerase stimulant | 0.02 0.007 CID_53481014 | CID_53481014 | |
| 0.054 | 0.078 | 0.1 | Na+ K+ transporting ATPase inhibitor | 0.1 0.031 CID_53481014 | CID_53481014 | |
| 0.042 | 0.07 | 0.1 | Heparanase inhibitor | 0.1 0.004 CID_53481014 | CID_53481014 | |
| 0.018 | 0.047 | 0.031 | Vanilloid 2 agonist | 0.031 0.008 CID_53481014 | CID_53481014 | |
| 0.105 | 0.135 | 0.132 | Protein-tyrosine phosphatase inhibitor | 0.132 0.099 CID_53481014 | CID_53481014 | |
| 0.021 | 0.051 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 CID_53481014 | CID_53481014 | |
| 0.038 | 0.07 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | 0.065 0.039 CID_53481014 | CID_53481014 | |
| 0.114 | 0.147 | 0.361 | Nitric oxide antagonist | 0.361 0.03 CID_53481014 | CID_53481014 | |
| 0.028 | 0.062 | 0.059 | Guanylate cyclase inhibitor | 0.059 0.012 CID_53481014 | CID_53481014 | |
| 0.051 | 0.084 | 0.06 | Interferon inducer | 0.06 0.055 CID_53481014 | CID_53481014 | |
| 0.152 | 0.187 | 0.401 | Peptidyltransferase inhibitor | 0.401 0.007 CID_53481014 | CID_53481014 | |
| 0.059 | 0.099 | 0.073 | Interferon agonist | 0.073 0.065 CID_53481014 | CID_53481014 | |
| 0.114 | 0.155 | 0.153 | CC chemokine 6 receptor antagonist | 0.153 0.018 CID_53481014 | CID_53481014 | |
| 0.128 | 0.173 | 0.29 | Platelet antagonist | 0.29 0.056 CID_53481014 | CID_53481014 | |
| 0.172 | 0.22 | 0.382 | Caspase 3 stimulant | 0.382 0.05 CID_53481014 | CID_53481014 | |
| 0.049 | 0.099 | 0.202 | Topoisomerase II alpha inhibitor | 0.202 0.015 CID_53481014 | CID_53481014 | |
| 0.096 | 0.146 | 0.161 | Diuretic | 0.161 0.068 CID_53481014 | CID_53481014 | |
| 0.04 | 0.094 | 0.064 | Leukotriene antagonist | 0.064 0.046 CID_53481014 | CID_53481014 | |
| 0.02 | 0.075 | 0.044 | Estrogen agonist | 0.044 0.039 CID_53481014 | CID_53481014 | |
| 0.012 | 0.074 | 0.091 | Sodium/glucose cotransporter 2 inhibitor | 0.091 0.003 CID_53481014 | CID_53481014 | |
| 0.032 | 0.1 | 0.07 | Leukotriene B4 antagonist | 0.07 0.02 CID_53481014 | CID_53481014 | |
| 0.096 | 0.184 | 0.303 | Hemostatic | 0.303 0.015 CID_53481014 | CID_53481014 | |
| 0.067 | 0.158 | 0.09 | Interleukin 12 antagonist | 0.09 0.072 CID_53481014 | CID_53481014 | |
| 0.159 | 0.252 | 0.363 | Apoptosis antagonist | 0.363 0.05 CID_53481014 | CID_53481014 | |
| 0.013 | 0.114 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.023 CID_53481014 | CID_53481014 | |
| 0.073 | 0.187 | 0.132 | Interleukin 4 antagonist | 0.132 0.069 CID_53481014 | CID_53481014 | |
| 0.033 | 0.151 | 0.049 | Factor III inhibitor | 0.049 0.038 CID_53481014 | CID_53481014 | |
| 0.026 | 0.152 | 0.053 | Cytokine production stimulant | 0.053 0.023 CID_53481014 | CID_53481014 | |
| 0.043 | 0.172 | 0.093 | Protein-tyrosine phosphatase 1B inhibitor | 0.093 0.086 CID_53481014 | CID_53481014 | |
| 0.048 | 0.181 | 0.126 | Uric acid excretion stimulant | 0.126 0.035 CID_53481014 | CID_53481014 | |
| 0.06 | 0.197 | 0.162 | Toll-Like receptor 4 antagonist | 0.162 0.015 CID_53481014 | CID_53481014 | |
| 0.053 | 0.192 | 0.094 | Thioredoxin inhibitor | 0.094 0.056 CID_53481014 | CID_53481014 | |
| 0.01 | 0.152 | 0.057 | Protein 30S ribosomal subunit inhibitor | 0.057 0.007 CID_53481014 | CID_53481014 | |
| 0.081 | 0.23 | 0.422 | Platelet adhesion inhibitor | 0.422 0.009 CID_53481014 | CID_53481014 | |
| 0.019 | 0.17 | 0.102 | Protein 50S ribosomal subunit inhibitor | 0.102 0.013 CID_53481014 | CID_53481014 | |
| 0.032 | 0.201 | 0.079 | Histone deacetylase stimulant | 0.079 0.044 CID_53481014 | CID_53481014 | |
| 0.032 | 0.201 | 0.079 | Histone deacetylase SIRT1 stimulant | 0.079 0.044 CID_53481014 | CID_53481014 | |
| 0.037 | 0.224 | 0.065 | Lipocortins synthesis agonist | 0.065 0.027 CID_53481014 | CID_53481014 | |
| 0.074 | 0.265 | 0.419 | Hepatoprotectant | 0.419 0.012 CID_53481014 | CID_53481014 | |
| 0.056 | 0.257 | 0.654 | Angiogenesis stimulant | 0.654 0.005 CID_53481014 | CID_53481014 | |
| 0.022 | 0.234 | 0.089 | Glucose-6-phosphate translocase inhibitor | 0.089 0.008 CID_53481014 | CID_53481014 | |
| 0.016 | 0.253 | 0.075 | Antibiotic Aminoglycoside-like | 0.075 0.005 CID_53481014 | CID_53481014 | |
| 0.039 | 0.285 | 0.322 | Thrombolytic | 0.322 0.02 CID_53481014 | CID_53481014 | |
| 0.018 | 0.268 | 0.084 | Neuraminidase (influenza) inhibitor | 0.084 0.023 CID_53481014 | CID_53481014 | |
| 0.014 | 0.273 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.03 CID_53481014 | CID_53481014 | |
| 0.013 | 0.288 | 0.34 | Selectin antagonist | 0.34 0.004 CID_53481014 | CID_53481014 | |
| 0.126 | 0.41 | 0.876 | Cyclophilin D inhibitor | 0.876 0.005 CID_53481014 | CID_53481014 | |
| 0.059 | 0.349 | 0.14 | Interleukin 6 antagonist | 0.14 0.106 CID_53481014 | CID_53481014 | |
| 0.01 | 0.326 | 0.071 | Neuraminidase inhibitor | 0.071 0.032 CID_53481014 | CID_53481014 | |
| 0.125 | 0.467 | 0.731 | Antiinflammatory | 0.731 0.025 CID_53481014 | CID_53481014 | |
| 0.005 | 0.349 | 0.023 | Motilin receptor agonist | 0.023 0.016 CID_53481014 | CID_53481014 | |
| 0.039 | 0.387 | 0.133 | Transcription factor NF kappa B stimulant | 0.133 0.02 CID_53481014 | CID_53481014 | |
| 0.064 | 0.42 | 0.426 | Immunosuppressant | 0.426 0.054 CID_53481014 | CID_53481014 | |
| 0.066 | 0.434 | 0.627 | Hypoglycemic | 0.627 0.007 CID_53481014 | CID_53481014 | |
| 0.035 | 0.429 | 0.209 | Hypolipemic | 0.209 0.088 CID_53481014 | CID_53481014 | |
| 0.071 | 0.476 | 0.535 | Immunomodulator | 0.535 0.018 CID_53481014 | CID_53481014 | |
| 0.043 | 0.45 | 0.2 | Insulin secretagoues | 0.2 0.036 CID_53481014 | CID_53481014 | |
| 0.038 | 0.486 | 0.352 | Tumour necrosis factor alpha release inhibitor | 0.352 0.037 CID_53481014 | CID_53481014 | |
| 0.024 | 0.496 | 0.177 | Anticoagulant | 0.177 0.063 CID_53481014 | CID_53481014 | |
| 0.027 | 0.512 | 0.179 | Cell adhesion inhibitor | 0.179 0.031 CID_53481014 | CID_53481014 | |
| 0.044 | 0.557 | 0.597 | Antiobesity | 0.597 0.021 CID_53481014 | CID_53481014 | |
| 0.014 | 0.541 | 0.079 | Cell adhesion molecule inhibitor | 0.079 0.054 CID_53481014 | CID_53481014 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |